LEE PHARMACEUTICALS
10QSB, 1998-08-04
PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS
Previous: LA-Z-BOY INC, 10-Q, 1998-08-04
Next: LEGGETT & PLATT INC, S-3, 1998-08-04



<PAGE>

                         SECURITIES AND EXCHANGE COMMISSION

                               Washington, DC  20549


                                    FORM 10-QSB


[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
     ACT OF 1934

For the quarterly period ended     June 30, 1998   
                               -------------------------------------------------

                                         OR

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES 
     EXCHANGE ACT OF 1934

For the transition period from               to          
                               -------------     --------------------------




Commission file number        1-7335
                       --------------------------------------------------------
                                       
                             LEE PHARMACEUTICALS
- --------------------------------------------------------------------------------
         (Exact name of small business issuer as specified in its charter)

              California                             95-2680312
- -------------------------------------  -----------------------------------------
   (State or other jurisdiction of       (I.R.S. Employer Identification No.)
    incorporation or organization)

             1444 Santa Anita Avenue,  South El Monte,  California 91733
- --------------------------------------------------------------------------------
                      (Address of principal executive offices)
                                   (Zip Code)
                                       
                              (626)  442-3141
- --------------------------------------------------------------------------------
                 (Registrant's telephone number, including area code)

                                      N/A
- --------------------------------------------------------------------------------
             (Former name, former address and former fiscal year,
                        if changed since last report)

     Check whether the registrant (1) filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements for the past
90 days.

Yes  X     No  
   -----     -----

     As of June 30, 1998, there were outstanding 4,135,162 shares of common
stock of the registrant.

     Transitional Small Business Disclosure Format (check one):
Yes        No  X    
   ------    ------

<PAGE>

                                                                     FORM 10-QSB
                                       
                             LEE PHARMACEUTICALS
                                BALANCE SHEET
                                JUNE 30, 1998
                            (DOLLARS IN THOUSANDS)
                                  (UNAUDITED)

<TABLE>

<S>                                                          <C>         <C>
ASSETS
Cash                                                                      $    9

Accounts and notes receivable (net of allowances: $171)                      738

Due from related party                                                       243

Inventories:
     Raw materials                                           $  1,620
     Work in process                                              273
     Finished goods                                               235
                                                             --------
     Total inventories                                                     2,128

Other current assets                                                         652
                                                                         -------
     Total current assets                                                  3,770

     Property, plant and equipment (less
     accumulated depreciation and
     amortization: $6,158)                                                   485
     
     Goodwill and other assets (net of
     accumulated amortization: $5,571)                                     2,187
                                                                         -------
     TOTAL                                                               $ 6,442
                                                                         -------
                                                                         -------
</TABLE>

                                          
                         See notes to financial statements.


<PAGE>

                                                                     FORM 10-QSB

                                          
                                LEE PHARMACEUTICALS 
                                   BALANCE SHEET
                                   JUNE 30, 1998
                               (DOLLARS IN THOUSANDS)
                                    (UNAUDITED)
     
<TABLE>

<S>                                                                   <C>
LIABILITIES
     
Bank overdraft                                                        $     144
Note payable to bank                                                          8
Notes payable, other                                                        933
Current portion - royalty agreements                                        269
Current portion - note payable related party                                345
Accounts payable                                                          1,008
Accrued liabilities - environmental cleanup                                 288
Other accrued liabilities                                                   576
Due to related parties                                                      480
Deferred income                                                              65
                                                                       --------
     Total current liabilities                                            4,116
     
Long-term notes payable to related parties                                2,970
     
Long-term notes payable, other                                              970
     
Long-term notes payable to bank                                             238
     
Long-term payable-royalty agreements, less current portion $269              25

Deferred income                                                              93
                                                                       --------
     Total liabilities                                                    8,412
                                                                       --------
     COMMITMENTS AND CONTINGENCIES
     
STOCKHOLDERS' DEFICIENCY
     
Common stock, $.10 par value; authorized, 7,500,00 shares;
     issued and outstanding, 4,135,162 shares                               413

Additional paid-in capital                                                4,222

Accumulated deficit                                                      (6,605)
                                                                       --------
     Total stockholders' deficiency                                      (1,970)
                                                                       --------
     TOTAL                                                             $  6,442
                                                                       --------
                                                                       --------

</TABLE>

                         See notes to financial statements.


<PAGE>

                                                                     FORM 10-QSB
                                          
                                LEE PHARMACEUTICALS
                                          
                              STATEMENTS OF OPERATIONS
                  (Dollars in thousands, except per share amounts)
                                          

<TABLE>
<CAPTION>

                                                     FOR THE THREE MONTHS          FOR THE NINE MONTHS
                                                          ENDED JUNE 30,              ENDED JUNE 30,
                                                      1998          1997            1998           1997
                                                  -----------   ------------    -----------    -----------
                                                   UNAUDITED)    (UNAUDITED)    (UNAUDITED)    (UNAUDITED)
<S>                                               <C>            <C>            <C>            <C>
Gross revenues                                    $    2,166     $    2,415     $    7,017     $    6,860
Less:     Sales returns                                 (199)          (158)          (556)          (503)
          Cash discounts and others                      (18)           (20)           (59)           (85)
                                                  ----------     ----------     ----------     ----------
Net revenues                                           1,949          2,237          6,402          6,272
                                                  ----------     ----------     ----------     ----------

Costs and expenses:

          Cost of sales                                  968            910          2,848          2,674
          Selling and advertising expense                901            866          2,690          2,405
          General and administrative expense             693            470          1,777          1,270
                                                  ----------     ----------     ----------     ----------
Total costs and expenses                               2,562          2,246          7,315          6,349
                                                  ----------     ----------     ----------     ----------
(Loss) from operations                                  (613)            (9)          (913)           (77)

Other income                                              18             19             54             65
                                                  ----------     ----------     ----------     ----------
Net income (loss)                                 $     (595)    $       10     $     (859)    $      (12)
                                                  ----------     ----------     ----------     ----------
                                                  ----------     ----------     ----------     ----------
Per share:
          Net income (loss)                       $     (.14)    $      .00     $     (.20)    $      .00
                                                  ----------     ----------     ----------     ----------
                                                  ----------     ----------     ----------     ----------
</TABLE>


                         See notes to financial statements.


<PAGE>

                                                                     FORM 10-QSB
                                          
                                LEE PHARMACEUTICALS 
                              STATEMENTS OF CASH FLOWS
                               (DOLLARS IN THOUSANDS)
<TABLE>
<CAPTION>

                                                                                  FOR THE NINE MONTHS
                                                                                     ENDED JUNE 30,
                                                                                   1998           1997
                                                                                -----------    ----------
                                                                                (UNAUDITED)    (UNAUDITED)
<S>                                                                             <C>            <C>
Cash flows from operating activities:
   Net (loss). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .      $     (859)    $      (12)
                                                                                ----------     ----------
   Adjustments to reconcile net loss to net
    cash provided by operating activities:
   Depreciation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .              93             83
   Amortization of intangibles . . . . . . . . . . . . . . . . . . . . . .             701          1,035
   (Decrease) in deferred income . . . . . . . . . . . . . . . . . . . . .             (49)           (49)
   (Gain) on disposal of property, plant, and equipment. . . . . . . . . .              (5)           (16)
Change in operating assets and liabilities:
   Decrease in accounts receivable . . . . . . . . . . . . . . . . . . . .             565            203
   (Increase) in due from related party. . . . . . . . . . . . . . . . . .            (135)           (21)
   (Increase) decrease in inventories  . . . . . . . . . . . . . . . . . .            (148)           166
   Decrease (increase) in other current assets . . . . . . . . . . . . . .             520            (62)
   (Decrease) in accounts payable. . . . . . . . . . . . . . . . . . . . .             (12)          (448)
   Increase (decrease) in account payable related party. . . . . . . . . .              75            (50)
   Increase in notes payable related party . . . . . . . . . . . . . . . .              90
   (Decrease) increase in notes payable, other . . . . . . . . . . . . . .             (48)            45
   Increase in accrued liabilities - environmental cleanup . . . . . . . .             201               
   Increase in other accrued liabilities . . . . . . . . . . . . . . . . .             256            133
   (Decrease) in accrued royalties . . . . . . . . . . . . . . . . . . . .            (856)           (76)
                                                                                ----------     ----------
   Total adjustments . . . . . . . . . . . . . . . . . . . . . . . . . . .           1,248            943
                                                                                ----------     ----------
     Net cash provided by operating activities . . . . . . . . . . . . . .             389            931
                                                                                ----------     ----------
Cash flows from investing activities:
   Additions to property, plant, and equipment . . . . . . . . . . . . . .             (61)          (111)
   Proceeds from sale of equipment . . . . . . . . . . . . . . . . . . . .               5             16
   Acquisition of product brands . . . . . . . . . . . . . . . . . . . . .             (70)        (1,092)
   Increase in long-term deposits. . . . . . . . . . . . . . . . . . . . .             (12)              
                                                                                ----------     ----------
     Net cash (used in) investing activities . . . . . . . . . . . . . . .            (138)        (1,187)
                                                                                ----------     ----------

Cash flows from financing activities:
   (Payments on) bank loans. . . . . . . . . . . . . . . . . . . . . . . .             (14)           (61)
   (Payments on) proceeds from notes payable to related party. . . . . . .             (94)            80
   Proceeds from notes payable, other. . . . . . . . . . . . . . . . . . .               3            633
   (Decrease) in long-term royalty agreements. . . . . . . . . . . . . . .             (96)          (495)
   (Decrease) increase in bank overdraft . . . . . . . . . . . . . . . . .             (65)           114
                                                                                ----------     ----------
     Net cash (provided by) used in financing activities . . . . . . . . .            (266)           271
                                                                                ----------     ----------

Net (decrease) increase in cash. . . . . . . . . . . . . . . . . . . . . .             (17)            15
Cash, beginning of year. . . . . . . . . . . . . . . . . . . . . . . . . .              26             13
                                                                                ----------     ----------

Cash, end of period. . . . . . . . . . . . . . . . . . . . . . . . . . . .      $        9     $       28
                                                                                ----------     ----------
                                                                                ----------     ----------

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:

Cash paid during the year for:
   Interest. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .      $      394     $      428
                                                                                ----------     ----------
                                                                                ----------     ----------

Acquisition of product brands:
   Fair value of assets acquired . . . . . . . . . . . . . . . . . . . . .      $       70     $    1,497
   Fair value of liabilities incurred. . . . . . . . . . . . . . . . . . .                            405
                                                                                ----------     ----------
     Net cash payments . . . . . . . . . . . . . . . . . . . . . . . . . .      $       70     $    1,092
                                                                                ----------     ----------
                                                                                ----------     ----------
</TABLE>

                          See notes to financial statements.


<PAGE>

                                                                     FORM 10-QSB

     NOTES TO FINANCIAL INFORMATION
     
1.   Basis of presentation:

     The accompanying balance sheet as of June 30, 1998, and the statements of
     operations and cash flows for the periods ended June 30, 1998, and 1997,
     have not been audited by independent accountants but reflect all
     adjustments, consisting of any normal recurring adjustments, which are, in
     the opinion of management, necessary to a fair statement of the results for
     such periods.  The results of operations for the nine months ended June 30,
     1998, are not necessarily indicative of results to be expected for the year
     ending September 30, 1998.

     Certain information and footnote disclosure normally included in financial
     statements prepared in accordance with generally accepted accounting
     principles have been omitted pursuant to the requirements of the Securities
     and Exchange Commission, although the Company believes that the disclosures
     included in these financial statements are adequate to make the information
     not misleading.

     The financial statements should be read in conjunction with the financial
     statements and notes thereto included in the Company's annual report on
     Form 10-KSB for the fiscal year ended September 30, 1997.

     The Company is involved in various matters involving environmental cleanup
     issues.  SEE "Item 2. Management's Discussion and Analysis or Plan of
     Operations" and Note 10 of Notes to Financial Statements included in the
     Company's Form 10-KSB for the fiscal year ended September 30, 1997.  The
     ultimate outcome of these matters cannot presently be determined. 
     Environmental expenditures that relate to an existing condition caused by
     past operations, and which do not contribute to current or future revenue
     generation, are expensed.  The Company's proportionate share of the
     liabilities are recorded when environmental remediation and/or cleanups are
     probable, and the costs can be reasonably estimated.

2.   Continued existence:

     The accompanying financial statements have been prepared assuming that the
     Company will continue as a going concern.  The Company's recurring past
     losses from operations and inability to generate sufficient cash flow from
     normal operations raise substantial doubt about its ability to continue as
     a going concern.  The financial statements do not include any adjustments
     to reflect the possible future effects on the recoverability and
     classification of assets or the amounts and classification of liabilities
     that may result from the possible inability of the Company to continued as
     a going concern.

3.   Net loss per share:

     Net loss per share is based on the weighted average number of shares of
     common stock outstanding during the periods presented.  Common stock
     equivalents (common stock options) are not included in these calculations
     where their effect on net loss per share is anti-dilutive.  The weighted
     average number of shares was 4,135,162 for all periods presented.

4.   Note payable to bank:

     Effective April 26, 1996, the Company renewed its real estate loan with the
     bank.  The note payable to the bank, secured by deed on land and building,
     requires a monthly payment of $4,200, including interest at Bank of
     America's base rate plus 4%, maturing March 2001.  At June 30, 1998, the
     interest rate was 12.5%.  The note is guaranteed by the former Chairman of
     the Company and the Company's President.

5.   Line of credit:

     During May of 1998, the Company renewed its revolving credit facility.  It
     is a two-year agreement maturing in May 2000.  The total revolving line of
     credit facility is $1,100,000, including a $400,000 loan secured by the
     Company's inventory at a rate of prime plus 6%.  Additionally, an equipment
     loan of $400,000 at a rate of prime plus 6% was made available.  The
     accounts receivable revolving credit facility is at a rate of prime plus
     5%.  The renewed interest rate is lower by 3% from the initial revolving
     credit facility agreement.  The equipment loan is amortized over 48 months
     with a balloon payment on May 21, 2000.  There is no prepayment penalty on
     either the equipment or inventory loan.  The accounts receivable line of
     credit could be paid off after May 20, 1999, with a 90 day advance notice 

<PAGE>

                                                                     FORM 10-QSB

     and $15,000 prepayment penalty.   The accounts receivable line of credit
     plus the inventory and equipment loans, in the aggregate, are subject to a
     minimum interest of $3,000 per month. The new loan agreement is personally
     guaranteed by the Company's president.

6.   Acquisitions:

     On October 16, 1996, the Company purchased certain assets from Lactona
     Corporation for $175,000 including inventory valued at approximately
     $30,000.  The Company remitted $75,000 at closing.  Payments of $3,000,
     including interest, are due the 16th of each month starting November 1996
     and ending September 1999 and any remaining amount on October 16, 1999. 
     Interest is to be computed at the highest prime rate during the payment
     period.  The highest prime rate was 8.25% on March 16, 1997.

     On October 21, 1996, the Company purchased certain assets from Roberts
     Laboratories, Inc. for $1,168,089.  The Company remitted $100,000 at
     closing.  Payments of $19,752 are due on the first of each month starting
     November 1, 1996, and ending on October 1, 2000.  Any remaining unpaid
     balance is due on November 1, 2000.  Interest shall be paid at the highest
     prime rate during the preceding month.

     On September 8, 1997, the Company purchased certain assets of the
     Klutch-Registered Trademark-denture adhesive powder line from I. Putnam,
     Inc. for $320,000.  The Company remitted $225,000 at closing and is
     required to make one payment of $7,000 plus interest, and eleven equal
     monthly payments of $8,000, plus interest at the prime rate.  In addition,
     the Company purchased certain inventories from I. Putnam, Inc. for $51,063
     at closing.

     On February 17, 1998, the Company purchased certain assets of the
     Painalay-Registered Trademark- throat spray line from Medtech Inc. for
     $70,000.  The Company is required to make five payments of $14,000 each
     plus interest at 10% starting 61 days after the close.  In addition, the
     Company purchased for cash inventory valued at $27,764.

ITEM 2.

     MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATIONS

     MATERIAL CHANGES IN RESULTS OF OPERATIONS
     THREE MONTHS ENDED JUNE 30, 1998, AND JUNE 30, 1997

     Gross revenues for the three months ended June 30, 1998, were $2,166,000, a
     decrease of approximately $249,000 or 10% from the comparable three months
     ended June 30, 1997.  The decrease in gross revenues was due to the decline
     in volume generated from the depilatories, nail products, oral rinse 
     powder, and the 28 items (acquired in October 1996) which includes 
     ointments, nutritional supplements, vitamins, analgesics and various 
     over-the-counter brands.  On the other hand, the above decreases in 
     sales volume were partially offset by increases in sales volume of 
     Lee-Registered Trademark-Lip-Ex-TM-, lip balm plus the added sales of the 
     newly acquired Klutch-Registered Trademark- and Painalay-Registered 
     Trademark- brands.

     Net revenues decreased approximately $288,000 or 13% for the three months
     ended June 30, 1998, as compared to the three months ended June 30, 1997. 
     The change in net revenues was due to the same explanation of the decrease
     in gross revenues discussed above.  In addition, the sales returns
     increased $41,000 or 26% when comparing the three months ended June 30,
     1998 and 1997.  The higher sales returns during the current quarter are
     attributable to the higher than normal level of returns related to the
     depilatory category.

     Cost of sales as a percentage of gross revenues was 45% for the quarter
     ended June 30, 1998, compared to 38% for the quarter ended June 30, 1997. 
     The cost of sales percentage was higher due to increased raw material
     purchases (normal quantity reordered, per purchase order, was tripled for
     certain high turnover items), increased manufacturing labor dollars as a
     result of two (September 1997 and March 1998) hourly rate increase
     increases (15%) in minimum wages and sale of some slow moving finished
     goods at lower than normal margins.

     Selling and advertising expenses increased $35,000 or 4% when comparing the
     three months ended June 30, 1998, with the three months ended June 30,
     1997.  The increases in expenses were mainly due to the following factors;
     (1) an increase in the amortization expense (approximately $13,000), and
     (2) an increase in salaries and wages plus related fringe benefits 
     ($88,000) as a result of new hires


<PAGE>

                                                                     FORM 10-QSB

     which included the addition of two outside salesmen, and higher related
     travel and entertainment expenses.  The above increases were partially
     offset by a decrease in the Company's co-operative advertising costs of
     approximately $53,000 when comparing the quarters ended June 30, 1998 and
     1997.

     General and administrative expenses increased when comparing the quarters
     ended June 30, 1998 and 1997.  The increase of $223,000 or 47% was the
     result of; (1) employee new hires (salary and wages) plus related fringe
     benefits, (2) an accrual of $79,000 (non-recurring) related to the Monterey
     Park waste site cleanup, (3) an accrual of $122,000 related to the
     Company's best estimate of its share of the remediation costs as described
     under "Environmental Matters," and (4) increased interest expense of
     approximately $28,000 as a result of increased borrowings from the
     Company's asset based financing lender.

     MATERIAL CHANGES IN RESULTS OF OPERATIONS
     NINE MONTHS ENDED JUNE 30, 1998, AND JUNE 30, 1997

     Gross revenues for the nine months ended June 30, 1998, were $7,017,000, an
     increase of approximately $157,000  or 2% from the comparable nine months
     period ended June 30, 1997.  The increase in gross revenues was due to the
     volume generated from the recently acquired brands such as: 
     Klutch-Registered Trademark- and Painalay-Registered Trademark-, plus the
     in-house product Lee-Registered Trademark- Lip-Ex-TM-, and the depilatory
     category.  The above increased sales volume was partially offset by reduced
     sales revenues of the nail category products.  Net revenues for the nine
     months ended June 30, 1998, were $6,402,000, an increase of $130,000 or 2%
     from the comparable nine months period ended June 30, 1997.  The reasons
     for higher sales returns during the nine months period ended June 30, 1998,
     versus June 30, 1997, was due to a higher level of returns related to the
     depilatory category which was offset in-part by lower nail extender product
     returns.

     Cost of sales as a percentage of gross revenues for the nine months ended
     June 30, 1998, as compared to the nine months period ended June 30, 1997,
     was 41% versus 39%, respectively.  The slightly higher cost of sales
     percentage for the nine months ended June 30, 1998, compared to June 30,
     1997, is due to the product mix in addition to the explanation above
     regarding the material changes for the three months ended June 30, 1998,
     versus 1997.

     Selling and advertising expenses increased $285,000 or 12% when comparing
     the nine months ended June 30, 1998, with the nine months ended June 30,
     1997.  The increased expenses were primarily due to:  (1) an increase in
     the amortization expense, (2) an increase in salaries and wages plus fringe
     benefits, the result of new hires which includes two outside salesmen, and
     higher related travel and entertainment expenses, (3) higher manufacture
     representative commissions, (4) higher product samples expense related to
     the new brand acquisitions, and (5) increased freight costs.  The
     aforementioned increased expenses were offset, in part, by a decrease in
     the cooperative advertising and print media advertising costs.

     General and administrative expenses increased $507,000 or 40% when
     comparing the nine months ended June 30, 1998, with the nine months ended
     June 30, 1997.  This significant increase was principally due to; (1)
     employee new hires (salary and wages) plus related fringe benefits, (2) an
     accrual of $79,000 (non-recurring) related to the Monterey Park waste site
     cleanup, (3) an accrual of $122,000 related to the Company's best estimate
     of its share of the remediation costs as described under "Environmental
     Matters," (4) increased interest expense of approximately $64,000 as a
     result of increased borrowings from the Company's asset based financial
     lender, and (5) slightly higher supplies and printing costs.

     LIQUIDITY AND CAPITAL RESOURCES

     At September 30, 1997, working capital was $114,000 and at June 30, 1998,
     the working capital was a negative $346,000, thus a decrease of $460,000. 
     The ratio of current assets to current liabilities was .9 to 1 at June 30,
     1998, and 1.0 to 1 at September 30, 1997.  The decrease in working capital
     of $460,000 (from a positive $114,000 to a negative $346,000) was basically
     due to a decrease in accounts receivable, prepaid royalties, and an
     increase in environmental cleanup cost liability.

     The Company has an accumulated deficit of $6,605,000.  The Company's
     recurring losses from operations and inability to generate sufficient cash
     flow from normal operations to meet its obligations as they came due raise
     substantial doubt about the Company's ability to continue as a going
     concern.  The Company's ability to continue in existence is dependent upon
     future developments, including retaining current financing and achieving a
     level of profitable operations sufficient to enable it to meet its
     obligations as they become due.


<PAGE>

                                                                     FORM 10-QSB

     ENVIRONMENTAL MATTERS

     The Company owns a manufacturing facility located in South El Monte,
     California.  The California Regional Water Quality Control Board (The
     "RWQCB") ordered the Company in 1988 and 1989 to investigate the
     contamination on its property (relating to soil and groundwater
     contamination).  The Company engaged a consultant who performed tests and
     reported to the then Chairman of the Company.  The Company resisted further
     work on its property until the property upgradient was tested in greater
     detail since two "apparent source" lots had not been tested.  On August 12,
     1991, the RWQCB issued a "Cleanup and Abatement Order" directing the
     Company to conduct further testing and cleanup the site.  In October 1991,
     the Company received from an environmental consulting firm an estimate of
     $465,200 for investigation and cleanup costs.  The Company believed that
     this estimate was inconclusive and overstated the contamination levels. 
     The Company believes that subsequent investigations will support the
     Company's conclusions about that estimate.  The Company did not complete
     the testing for the reasons listed above as well as "financial
     constraints".  In June 1992 the RWQCB requested that the EPA evaluate the
     contamination and take appropriate action.  At the EPA's request, Ecology &
     Environment, Inc. conducted an investigation of soil and groundwater on the
     Company's property.  Ecology & Environment Inc.'s Final Site Assessment
     Report, which was submitted to the EPA in June 1994, did not rule out the
     possibility that some of the contamination originated on-site, and resulted
     from either past or current operations on the property.  The Company may be
     liable for all or part of the costs of re mediating the contamination on
     its property.  The EPA has not taken any further action in this matter, but
     may do so in the future.

     The Company and nearby property owners, in consort with their comprehensive
     general liability (GLC) carriers, have engaged a consultant to perform a
     site investigation with respect to soil and shallow groundwater
     contamination over the entire city block.  The CGL carriers provided
     $290,000 in funding which paid for the $220,000 study, $20,000 in legal
     fees for project oversight, and a $50,000 balance in the operating fund. 
     Earlier the Company had accrued $87,500 as its proportionate share of the
     earlier quote of $175,000.  Since that time, the overall scope of the
     project was increased to $205,000 plus $15,000 for waste water disposal,
     bringing the total to the above listed $220,000.  The $87,500 accrual was
     not spent on this project (as the entire cost was borne by the
     comprehensive general liability carriers), but remains on the books as an
     accrual against the cost of remediation of the same site that was included
     in the study.

     The tenants of nearby properties upgradient have sued the Company alleging
     that hazardous materials from the Company's property caused contamination
     on the properties leased by the tenants.  The case name is DEL RAY
     INDUSTRIAL ENTERPRISES, INC. v. ROBERT MALONE, ET AL., Los Angeles County
     Superior Court, Northwest District, commenced August 21, 1991.  In this
     action, the plaintiff alleges environmental contamination by defendants of
     its property, and seeks a court order preventing further contamination and
     monetary damages.  The Company does not believe there is any basis for the
     allegations and is vigorously defending the lawsuit.

     The Company's South El Monte manufacturing facility is also located over a
     large area of possibly contaminated regional groundwater which is part of
     the San Gabriel Valley Superfund site.  The Company has been notified that
     it is a potentially responsible party ("PRP") for the contamination.  In
     1995, the Company was informed that the EPA estimated the cleanup costs for
     the South El Monte's portion of the San Gabriel Valley Superfund site to be
     $30 million.  The Company's potential share of such amount has not been
     determined.  Superfund PRPs are jointly and severally liable for superfund
     site costs, and are responsible for negotiating among themselves the
     allocation of the costs based on, among other things, the outcome of
     environmental investigation.

     In August 1995 the Company was informed that the EPA entered into an
     Administrative Order of Consent with Cardinal Industrial Finishes
     ("Cardinal") for a PRP lead remedial investigation and feasibility study
     (the "Study") which, the EPA states, will both characterize the extent of
     groundwater contamination in South El Monte and analyze alternatives to
     control the spread of contamination.  The Company and others have entered
     into the South El Monte Operable Unit Site Participation Agreement with
     Cardinal pursuant to which, among other things, Cardinal will contract with
     an environmental firm to conduct the Study.  The Study has been completed
     but the final program has not been reported.  The Company's share of the
     cost of the Study is currently $15,000 and was accrued for in the financial
     statements as of September 30, 1995.

     The City of South El Monte, the city in which the Company has its
     manufacturing facility, is located in the San Gabriel Valley.  The San
     Gabriel Valley has been declared a Superfund site.  The 1995 Water Quality
     Control Plan issued by the California Regional Water Quality Control Board
     states that the primary groundwater basin pollutants in the San
     Gabriel Valley are volatile organic compounds from

<PAGE>

                                                                     FORM 10-QSB

     industry, nitrates from subsurface sewage disposal and past agricultural
     activities.  In addition, the Plan noted that hundreds of underground
     storage tanks leaking gasoline and other toxic chemicals have existed in
     the San Gabriel Valley.  The California Department of Toxic Substance
     Control have declared large areas of the San Gabriel Valley to be
     environmentally hazardous and subject to cleanup work.

     The Company believes the City of South El Monte does not appear to be
     located over any of the major plumes.  However, the EPA recently announced
     it is studying the possibility that, although the vadose soil and
     groundwater, while presenting cleanup problems, there may be a
     contamination by DNAPs (dense non-aqueous phase liquids), i.e., "sinkers",
     usually chlorinated organic cleaning solvents.  The EPA has proposed to
     drill six "deep wells" throughout the City of South El Monte at an
     estimated cost of $1,400,000.  The EPA is conferring with SEMPOA (South El
     Monte Property Owners Association) as to cost sharing on this project. 
     SEMPOA has obtained much lower preliminary cost estimates.  The outcome
     cost and exact scope of this are unclear at this time.

     The Company and other property owners engaged Geomatrix Consultants, Inc.,
     to do a survey of vadose soil and shallow groundwater in the "hot spots"
     detected in the previous studies.  Geomatrix issued a report dated December
     1, 1997 (the "Report"), on the impact of volatile organic compounds on the
     soil and groundwater at the Lidcombe and Santa Anita Avenue site located in
     South El Monte, California (which includes the Company's facilities).  The
     Report indicated generally low concentrations of tetrachloroethene,
     trichloaethene and trichloroethane in the groundwater of the upgradient
     neighbor.  The Report was submitted to the RWQCB for its comments and
     response.  A meeting with the parties and RWQCB was held on February 10,
     1998.  The RWQCB had advised companies that vadose soil contamination is
     minimal and requires no further action.  However, there is an area of
     shallow groundwater which has a higher than desired level of chlorinated
     solvents, and the RWQCB requested a proposed work plan be submitted by
     Geomatrix.  Geomatrix has submitted a "Focused Feasibility Study" which
     concludes that there are five possible methods for cleanup.  The most
     expensive are for a pump and sewer remediation which would cost between
     $1,406,000 and $1,687,000.  The Company is actively exploring the less
     expensive alternative remediation methods, of which the two proposed
     alternatives range in cost between $985,000 and $1,284,000.  Accordingly,
     the Company has taken the average of the two amounts ($985,000 and
     $1,284,000) as the total amount of estimated cost.  Since there are four
     economic entities involved, the Company's best estimate at this time, in
     their judgment, would be that their forecasted share would be 25% or
     $284,000 less the liability already recognized on the books of $162,000
     thereby requiring an additional $122,000 liability.  Accordingly, the
     Company recorded an additional accrual of $122,000 in the third quarter of
     fiscal 1998.  The $122,000 accrual is in addition to the $79,000 accrual
     for the Monterey Site as will be explained in the following paragraph.  The
     $79,000 accrual, in the third quarter of fiscal 1998, related to the
     Monterey Site is not included in the $284,000 figure above.  No assurances
     can be given that any of the alternative remediation methods will be
     feasible or that the actual cost to the Company of the remediation will not
     exceed the amount of the Company's current accruals of $284,000 (which
     includes the $122,000 charge to income for this quarter).

     Without any prior correspondence or inkling of the Company's potential
     liability, the EPA has recently informed the Company that the Company may
     have potential liability for the ongoing remediation of Operating
     Industries, Inc. (as they have gone out of business) Landfill Superfund
     Site in Monterey Park, California (the "Monterey Site").  The Monterey Site
     is a 190 acre landfill that operated from 1948 to 1984, in which the
     Company disposed of non toxic pH balanced waste water on six occasions
     between 1974 and 1978.  Over 4,000 companies have been identified as having
     contributed waste to the Monterey Site.  The EPA has offered to settle the
     Company's potential liability with respect to the Monterey Site for a cost
     to the Company of $79,233.  The Company accrued a $79,000 charge in the
     third quarter of fiscal 1998 with respect to this possible liability.  The
     Company has forwarded this proposal to its environmental counsel for their
     review of the Company's available options.

     The Company continues to seek reimbursement from various CGL carriers,
     although there can be no assurances that any such payments will be
     received.  Some carriers have denied liability for costs, based on their
     review and analysis of the insurance policies, the history of the site, the
     nature of the claims, and current court decisions in such cases.

     The total amount of environmental investigation and cleanup costs that the
     Company may incur with respect to the foregoing is not known at this time. 
     However, based upon information available to the Company at this time, the
     Company has expensed since 1988 a total of $486,000, of which $89,000 were
     legal fees, exclusive of legal fees expended in connection with the SEC
     environmental investigation.  The actual costs could differ materially from
     the amounts expensed for environmental investigation and cleanup costs to
     date.


<PAGE>

                                                                     FORM 10-QSB

PART II - OTHER INFORMATION

Item 1.   Legal Proceedings

The information set forth under Part I, Item 2, "Management's Discussion and
Analysis or Plan of Operations - Environmental Matters" is incorporated herein
by reference.  SEE ALSO "Legal Proceedings" in the Company's Form 10-KSB for the
fiscal year ended September 30, 1997.

Item 6.   Exhibits

          3.1     -      Articles of Incorporation, as amended  (1)

          3.4     -      By-laws, as amended December 20, 1977  (2)

          3.5     -      Amendment of By-laws effective March 14, 1978  (2)

          3.6     -      Amendment to By-laws effective November 1, 1980  (3)

         10.1     -      Modification of loan and security agreement dated May
                         21, 1996, between Lee Pharmaceuticals and Preferred
                         Business Credit, Inc. regarding a revolving credit
                         facility financing.

         10.2     -      Modification of secured promissory note dated August
                         29, 1997, between Lee Pharmaceuticals and Preferred
                         Business Credit, Inc.

         10.3     -      Secured promissory note dated May 15, 1998, between Lee
                         Pharmaceuticals and Preferred Business Credit, Inc.

         10.4     -      Continuing guaranty dated May 15, 1998, between Lee
                         Pharmaceuticals and Preferred Business Credit, Inc.

           27     -      Financial Data Schedule

          (1)     Filed as an Exhibit of the same number with the Company's Form
                  S-1 Registration Statement filed with the Securities and
                  Exchange Commission on February 5, 1973, (Registrant No.
                  2-47005), and incorporated herein by reference.

          (2)     Filed as Exhibits 3.4 and 3.5 with the Company's Form 10-K
                  Annual Report for the fiscal year ended September 30, 1978,
                  filed with the Securities and Exchange Commission and
                  incorporated herein by reference.

          (3)     Filed as an Exhibit of the same number with the Company's Form
                  10-K Annual Report for the fiscal year ended September 30,
                  1979, filed with the Securities and Exchange Commission and
                  incorporated herein by reference.


<PAGE>

                                                                     FORM 10-QSB


                                     SIGNATURES
     
     In accordance with the requirements of the Securities Exchange Acts of
     1934, the registrant has caused this report to be signed on its behalf by
     the undersigned thereunto duly authorized.

                                                     LEE PHARMACEUTICALS
                                                     -------------------
                                                         (Registrant)
                                        
                                        
Date:  August 3, 1998                                   Ronald G. Lee
     ------------------                      ----------------------------------
                                                        Ronald G. Lee
                                             President (Chief Executive Officer
                                                and Chief Financial Officer)

<PAGE>

                                                               EXHIBIT 10.1
                                                               PAGE 1 of 2

                 MODIFICATION OF LOAN AND SECURITY AGREEMENT

WHEREAS this agreement is in reference to a loan which is evidenced by an 
instrument entitled LOAN AND SECURITY AGREEMENT ("AGREEMENT"), dated May 21, 
1996, executed by and between LEE PHARMACEUTICALS as "BORROWER" and PREFERRED 
BUSINESS CREDIT, INC. ("PBC"), as "LENDER."

NOW THEREFORE, it is agreed by the undersigned parties that the AGREEMENT 
shall be amended in the following respect:

   In Section 2.1(a) of the Agreement, PBC agrees to make revolving 
   advances to Borrower in an amount equal to the lesser of (I) Seventy 
   five percent (75%) of the amount of Eligible Accounts; and (II) an 
   amount equal to Borrower's cash collections for the immediately 
   preceding forty-five (45) day period.

   In Section 2.1(b) of the Agreement, PBC agrees to make revolving 
   advances to Borrower in an amount equal to the lesser of (I) twenty five 
   percent (25%) of the amount of Eligible Inventory, (II) the outstanding 
   balance of advances against Eligible Accounts and (III) Four Hundred 
   Thousand and 00/100 Dollars ($400,000.00) evidenced by a Secured 
   Promissory Note dated May 15, 1998.
   
   In Section 2.1 of the Agreement, PBC shall have no obligation to make 
   advances hereunder to the extent they would cause the outstanding 
   balance of revolving advances under this Section 2.1 to exceed a maximum 
   amount of One Million One Hundred Thousand and 00/100 Dollars 
   ($1,100,000.00).
   
   In Section 2.4(a) of the Agreement, The obligations shall bear interest, 
   on the average Daily Balance, at a rate of Five percentage points (5%) 
   above the Prime Rate.
   
   In Section 3.1 of the Agreement, This Agreement shall become effective 
   and shall continue in full force and effect for a term ending May 21, 
   2000.

   In Section 3.3 of the Agreement, After May 21, 1999, the Borrower has 
   the option, on ninety (90) days prior written notice to PBC, to 
   terminate this Agreement on a date other than an anniversary of the 
   effective date by paying to PBC, in cash, the Obligation together with 
   all accrued and unpaid interest and expense and a prepayment penalty of 
   Fifteen Thousand Dollars ($15,000.00).

<PAGE>

                                                               EXHIBIT 10.1
                                                               PAGE 2 of 2

   Borrower hereby rescind the termination letter dated February 16, 1998.

Except as noted above, all the terms, conditions and provisions of said 
AGREEMENT shall remain unchanged and in full force and effect.

DATE:  May 15, 1998

PREFERRED BUSINESS CREDIT, INC.    AGREED AND ACCEPTED:
                                   LEE PHARMACEUTICALS

BY: /s/ Farhad Motia 
   ----------------------------
    Farhad Motia, President
                                   BY: /s/ Ronald G. Lee
                                      ------------------------
                                      Ronald G. Lee, President

<PAGE>
                                                                  EXHIBIT 10.2

                   MODIFICATION OF SECURED PROMISSORY NOTE

WHEREAS this agreement is in reference to a loan which is evidenced by an 
instrument entitled Secured Promissory Note, (NOTE), dated August 29, 1997 
executed by LEE PHARMACEUTICALS for the original principal sum of One Hundred 
Thirty Eight Thousand and 00/100 Dollars ($138,000.00) and payable to the 
order of PREFERRED BUSINESS CREDIT, INC.

Principal balance outstanding on this Note as of this date is EIGHTY THOUSAND 
THREE HUNDRED TWENTY SEVEN AND 13/100 DOLLARS ($80,327.13).

NOW THEREFORE, it is agreed by the undersigned parties that the Note shall be 
amended in the following respect:

This Note shall bear interest at the rate of 14.5%, computed on the basis of 
a 360 day year for actual days elapsed.

The term of this Note shall be extended to May 21, 2000.


Except as noted above, all the terms, conditions and provisions of said Note 
shall remain unchanged and in full force and effect.

Date: May 15, 1998                     Loan Number: LEE05

PREFERRED BUSINESS CREDIT, INC.        LEE PHARMACEUTICALS
a California corporation               a California corporation
- ------------------------------         ----------------------------

By: /s/ Farhad Motia                   By: /s/ Ronald G. Lee
   ---------------------------             -------------------------
   Farhad Motia, President                 Ronald G. Lee, President





<PAGE>

                                                                EXHIBIT 10.3
                                                                PAGE 1 of 2

                           SECURED PROMISSORY NOTE


$400,000.00                                               Pasadena, California
- -----------                                               May 15, 1998

FOR VALUE RECEIVED, the undersigned hereby jointly and severally (if 
applicable) promises to pay to PREFERRED BUSINESS CREDIT, INC., a California 
Corporation, at 300 N. Lake Ave., Pasadena, California, 91101, or at such 
other address as the holder may specify in writing, the principal sum of Four 
Hundred Thousand and 00/100 Dollars ($400,000.00) plus interest as provided 
below.

This note shall bear interest at the rate of 14.50% per annum, computed on 
the basis of a 360 day year for actual days elapsed. This rate is based upon 
the prime rate of interest of 8.50%, the rate in effect as of this date. The 
prime rate of interest is the prime rate announced as being charged by Bank 
of America, San Francisco, from time to time. In the event the prime rate is 
from time to time hereafter changed, the rate of interest provided in this 
note shall be correspondingly changed. For each month the rate of interest 
charged under this note shall be based upon the average prime rate in effect 
during such month. In no event shall the rate of interest chargeable 
hereunder be less than 1% per month.

Principal shall be payable in 10 equal monthly installments of $11,111.00 
commencing August 1, 1998 and continue thereafter on the 1st day of each 
month, plus interest shall be payable monthly commencing June 1, 1998 and 
continue thereafter on the 1st day of each month, and one final installment 
on May 21, 2000 equal to all principal outstanding together with all accrued 
and unpaid interest.

This note is secured by that certain Loan and Security Agreement 
("Agreement") dated May 21, 1996 and is subject to all of the terms and 
conditions thereof. In the event of default under the Agreement, including 
but not limited to, the failure to pay any installment of principal or 
interest hereunder when due, the holder of this note may, at its election and 
without notice to the undersigned, declare the entire balance hereof 
immediately due and payable.

If any installment of principal or interest hereunder is not paid when due, 
the holder shall have the following rights in addition to the rights set 
forth in the preceding paragraph: (a) the right to add unpaid interest 
to principal and to have such amount thereafter bear interest as provided in 
this note, and (b) if any installment is more than ten days past due, the 
right to collect a charge equal to the greater of $15.00 or five percent of 
the delinquent payment. This charge is the result of a reasonable endeavor by 
the undersigned and the holder to estimate the holder's added costs and 
damages resulting from the undersigned's failure to timely make payments 
under this note; hence the undersigned agrees that the charge shall be 
presumed to be the amount of damage sustained by the holder since it is 
extremely difficult to determine the actual amount necessary to reimburse 
the holder of such damages. If this note is not paid when due, the 
undersigned further promises to pay all costs of collection, foreclosure 
fees and reasonable attorneys' fees incurred by the holder whether or not
suit is filed hereon.

<PAGE>

                                                                EXHIBIT 10.3
                                                                PAGE 2 of 2

Provided the undersigned is not then in default hereunder or under any other 
agreement with the holder of this note, this note may be prepaid at any time 
after one year from the date hereof by paying the balance of principal owing 
plus all accrued and unpaid interest and charges, together with a prepayment 
charge of N/A on the amount prepaid.

Presentment for payment, notice of dishonor, protest, and notice of protest 
are expressly waived. This note cannot be changed, modified, amended or 
terminated orally.

WAIVER OF TRIAL BY JURY. THE UNDERSIGNED, TO THE EXTENT IT MAY LEGALLY DO SO, 
HEREBY EXPRESSLY WAIVES ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, 
ACTION, CAUSE OF ACTION, OR PROCEEDING ARISING UNDER OR WITH RESPECT TO THIS 
NOTE, OR IN ANY WAY CONNECTED WITH, OR RELATED TO, OR INCIDENTAL TO, THE 
DEALINGS OF THE PARTIES HERETO WITH RESPECT TO THIS NOTE OR THE TRANSACTIONS 
RELATED THERETO, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND 
IRRESPECTIVE OF WHETHER SOUNDING IN CONTRACT, TORT OR OTHERWISE. THE 
UNDERSIGNED, TO THE EXTENT IT MAY LEGALLY DO SO, HEREBY AGREES THAT ANY SUCH 
CLAIM, DEMAND, ACTION, CAUSE OF ACTION, OR PROCEEDING SHALL BE DECIDED BY A 
COURT TRIAL WITHOUT A JURY AND THAT THE HOLDER OF THIS NOTE MAY FILE AN 
ORIGINAL COUNTERPART OR A COPY OF THIS SECTION WITH ANY COURT AS WRITTEN 
EVIDENCE OF THE CONSENT OF THE UNDERSIGNED TO THE WAIVER OF ITS RIGHT TO 
TRIAL BY JURY.

IN WITNESS WHEREOF, this Note has been executed and delivered on the date 
first set forth above.

                                       LEE PHARMACEUTICALS
                                       a California corporation

                                       By: /s/ Ronald G. Lee
                                          ------------------------
                                          Ronald G. Lee, President

<PAGE>

                                                                EXHIBIT 10.4
                                                                PAGE 1 of 8

                             CONTINUING GUARANTY

     THIS CONTINUING GUARANTY ("Guaranty"), dated as of May 15, 1998, is 
executed and delivered by Ronald G. Lee, ("Guarantor") in favor of PREFERRED 
BUSINESS CREDIT, INC., a California Corporation ("PBC") and in light of the 
following:

     FACT ONE: Borrower and PBC are, contemporaneously herewith, entering 
into the Loan Documents; and

     FACT TWO: In order to induce PBC to extend financial accommodation to 
LEE PHARMACEUTICALS, a California corporation, ("Borrower") pursuant to the 
Loan Documents, and in consideration thereof, and in consideration of any 
loans or other financial accommodations heretofore or hereafter extended by 
PBC to Borrower, whether pursuant to the Loan Documents or otherwise, 
Guarantor has agreed to guarantee the Guaranteed Obligations.

     NOW, THEREFORE, in consideration of the foregoing, Guarantor hereby 
agrees, in favor of PBC, as follows:

     1.  DEFINITIONS AND CONSTRUCTION.

          (a)  DEFINITION. The following terms, as used in this Guaranty, 
shall have the following meanings:

               "BANKRUPTCY CODE" means The Bankruptcy Reform Act of 1978 (11 
U.S.C. Sections 101-1330), as amended or supplemented from time to time, and 
any successor statute, and any and all rules issued or promulgated in 
connection therewith.

               "GUARANTEED OBLIGATIONS" means any and all obligations, 
indebtedness, or liabilities of any kind or character owed by Borrower to PBC 
including all such obligations, indebtedness, or liabilities, whether for 
principal, interest (including any interest which, but for the application of 
the provisions of the Bankruptcy Code, would have accrued on such amounts), 
premium, reimbursement obligations, fees, costs, expenses (including, 
attorneys' fees), or indemnity obligations, whether heretofore, now, or 
hereafter made, incurred, or created, whether voluntarily or involuntarily 
made, incurred, or created, whether secured or unsecured (and if secured, 
regardless of the nature of extent of the security), whether absolute or 
contingent, liquidated or unliquidated, determined or indeterminate, whether 
Borrower is liable individually or jointly with others, and whether recovery 
is or hereafter becomes barred by any statute of limitations or otherwise 
becomes unenforceable for any reason whatsoever, including any act or failure 
to act by PBC.

               "LOAN DOCUMENTS" shall mean that certain Loan and Security 
Agreement dated May 21, 1996 between PBC and Borrower, any promissory notes 
issued by Borrower in connection therewith, and those documents, instruments, 
and agreements which either now or in the future exist among Borrower, 
Guarantor, or any affiliate of Borrower, on the one hand, and PBC, on the 
other hand.

                                      1

<PAGE>

                                                                EXHIBIT 10.4
                                                                PAGE 2 of 8

               (b) CONSTRUCTION. Unless the context of this Guaranty clearly 
requires otherwise, references to the plural include the singular, references 
to the singular include the plural, and the term "including" is not limiting. 
The words "hereof," "herein," "hereby," "hereunder," and other similar terms 
refer to this Guaranty as a whole and not to any particular provision of this 
Guaranty. Any reference herein to any of the Loan Documents includes any and 
all alterations, amendments, extensions, modifications, renewals, or 
supplements thereto or thereof, as applicable. Neither this Guaranty nor any 
uncertainty or ambiguity herein shall be construed or resolved against PBC or 
Guarantor, whether under any rule of construction or otherwise. On the 
Contrary, this Guaranty has been reviewed by Guarantor, PBC, and their 
respective counsel, and shall be construed and interpreted according to the 
ordinary meaning of the words used so as to fairly accomplished the purposes 
and intentions of PBC and Guarantor.

     2.  GUARANTEED OBLIGATIONS. Guarantor hereby irrevocably and 
unconditionally guarantees to PBC, as and for its own debt, until final and 
indefeasible payment thereof has been made, (a) payment of the Guaranteed 
Obligations, in each case when and as the same shall become due and payable, 
whether at maturity, pursuant to a mandatory prepayment requirement, by 
acceleration, or otherwise; it being the intent of Guarantor that the 
guaranty set fourth herein shall be a guaranty of payment and not a guaranty 
of collection; and (b) the punctual and faithful performance, keeping, 
observance, and fulfillment by Borrower of all of the agreements, conditions, 
covenants, and obligations of Borrower contained in the Loan Documents.

     3.  CONTINUING GUARANTY. This Guaranty includes Guaranteed Obligations 
arising under successive transactions continuing, compromising, extending, 
increasing, modifying, releasing, or renewing the Guaranteed Obligations, 
changing the interest rate, payment terms, or other terms and conditions 
thereof, or creating new or additional Guaranteed Obligations after prior 
Guaranteed Obligations have been satisfied in whole or in part. To the 
maximum extent permitted by law, Guarantor hereby waives any right to revoke 
this Guaranty as to future indebtedness. If such a revocation is effective 
notwithstanding the foregoing waiver, Guarantor acknowledges and agrees that 
(a) no such revocation shall be effective until written notice thereof has 
been received by PBC, (b) no such revocation shall apply to any Guaranteed 
Obligations in existence on such date (including, any subsequent 
continuation, extension, or renewal thereof, or change in the interest rate, 
payment terms, or other terms and conditions thereof), (c) no such revocation 
shall apply to any Guaranteed Obligations made or created after such date to 
the extent made or created pursuant to a legally binding commitment of PBC in 
existence on the date of such revocation, (d) no payment by Guarantor, 
Borrower, or from any other source, prior to the date of such revocation 
shall reduce the maximum obligation of Guarantor hereunder, and (e) any 
payment by Borrower or from any source other than Guarantor, subsequent to 
the date of such revocation, shall first be applied to that portion of the 
Guaranteed Obligations as to which the revocation is effective and which are 
not, therefore, guaranteed hereunder, and to the extent so applied shall not 
reduce the maximum obligation of Guarantor hereunder.

     4.  PERFORMANCE UNDER THIS GUARANTY.  In the event that Borrower fails 
to make any payment of any Guaranteed Obligations on or before the due date 
thereof, or if Borrower shall fail to perform, keep, observe, or fulfill any 
other obligation referred to in clause (b) of Section 2 hereof in the manner 
provided in the Loan Documents, Guarantor immediately shall cause such 
payment to be made or each of such obligations to be performed, kept, 
observed, or fulfilled.

                                     2 

<PAGE>

                                                           EXHIBIT 10.4
                                                           PAGE 3 of 8


     5.  PRIMARY OBLIGATIONS.  This Guaranty is a primary and original 
obligation of Guarantor, is not merely the creation of a surety relationship, 
and is an absolute, unconditional, and continuing guaranty of payment and 
performance which shall remain in full force and effect without respect to 
future changes in conditions, including any change of law or any invalidity 
or irregularity with respect to the issuance of the Notes. Guarantor agrees 
that it is directly, jointly and severally with any other guarantor of the 
Guaranteed Obligation, liable to PBC, that the obligations of Guarantor 
hereunder are independent of the obligations of Borrower or any other 
guarantor, and that a separate action may be brought against Guarantor 
whether such action is brought against Borrower or any other guarantor or 
whether Borrower or any such other guarantor is joined in such action. 
Guarantor agrees that its liability hereunder shall be immediate and shall 
not be contingent upon the exercise or enforcement by PBC of whatever 
remedies it may have against Borrower or any other guarantor, or the 
enforcement of any lien or realization upon any security PBC may at any time 
possess. Guarantor agrees that any release which may be given by PBC to 
Borrower or any guarantor shall not release Guarantor. Guarantor consents and 
agrees that PBC shall be under no obligation to marshal any assets of 
Borrower or any other guarantor in favor of Guarantor, or against or in 
payment of any or all of the Guaranteed Obligations.

     6.  WAIVERS.

         (a)  Guarantor hereby waives: (1) notice of acceptance hereof; (2) 
notice of any loans or other financial accommodations made or extended under 
the Loan Documents or the creation or existence of any Guaranteed 
Obligations; (3) notice of the amount of the Guaranteed Obligations, subject, 
however, to Guarantor's right to make inquiry of PBC to ascertain the amount 
of the Guaranteed Obligations at any reasonable time;  (4) notice of any 
adverse change in the financial condition of Borrower or of any other fact 
that might increase Guarantor's risk hereunder; (5) notice of presentment for 
payment, demand, protest, and notice thereof as to any promissory notes or 
other instruments among the Loan Documents; (6) notice of any event of 
default under the Loan Documents; and (7) all other notices (except if such 
notice is specifically required to be given to Guarantor hereunder or under 
any Loan Document to which Guarantor is a party) and demands to which 
Guarantor might otherwise be entitled.

         (b)  To the maximum extent permitted by law, Guarantor hereby waives 
the right by statute or otherwise to require PBC to institute suit against 
Borrower or to exhaust any rights and remedies which PBC has or may have 
against Borrower. In this regard, Guarantor agrees that it is Bound to the 
payment of all Guaranteed Obligations, whether now existing or hereafter 
accruing, as fully as if such Guaranteed Obligations were directly owing to 
PBC by Guarantor. Guarantor further waives any defense arising by reason of 
any disability or other defense (other than the defense that the Guaranteed 
Obligations shall have been fully and finally performed and indefeasibly 
paid) of Borrower or by reason of the cessation from any cause whatsoever of 
the liability of Borrower in respect thereof.

         (c)  To the maximum extent permitted by law, Guarantor hereby 
waives: (1) any rights to assert against PBC any defense (legal or 
equitable), set-off, counterclaim, or claim which Guarantor may now or at any 
time hereafter have against Borrower or any other party liable to PBC; (2) 
any defense, set-off, counterclaim, or claim, of any kind or nature, arising 
directly or indirectly from the present or future lack of perfection, 
sufficiency, validity, or enforceability of the Guaranteed Obligations or any 
security therefor; (3) any defense arising by reason of any claim of defense 
based upon an election or remedies by PBC including the provisions of 
Sections 580d and 726 of the California Code of Civil Procedure, or any 
similar law of California or any other jurisdiction; (4) the guarantor 
expressly waives

                                     3

<PAGE>

                                                           EXHIBIT 10.4
                                                           PAGE 4 of 8


any and all defenses in its favor based upon an election of remedies by the 
PBC which destroys, diminishes or affects the guarantor's subrogation rights 
against the borrower and/or the guarantor's rights to proceed against the 
borrower for reimbursement, contribution, indemnity or otherwise, including 
without limitation any election(s) by PBC to conduct a nonjudicial fore 
closure sale under any deed(s) of trust, and further including without 
limitation any and all defenses, rights or stoppels which might otherwise 
arise under or in connection with California Civil Code of Civil Procedure 
("CCP") Section 580d or 580a as a result of any such election(s) or 
otherwise. The guarantor acknowledges and agrees that it is knowingly waiving 
in advance as a result of the foregoing sentence a complete or partial 
defense to its guaranty it may later have had arising from CCP Section 580d 
or 580a based upon PBC's subsequent election to conduct a private nonjudicial 
foreclosure sale, even though such election would destroy, diminish or affect 
the guarantor's rights of subrogation against the borrower and the 
guarantor's rights to pursue the borrower for reimbursement, contribution, 
indemnity or otherwise. (5) the benefit of any statute of limitations 
affecting Guarantor's liability hereunder or the enforcement thereof, and any 
act which shall defer or delay the operation of any statute of limitations 
applicable to the Guaranteed Obligations shall similarly operate to defer or 
delay the operation of such statute of limitations applicable to guarantor's 
liability hereunder.

         (d)  To the maximum extent permitted by law, Guarantor hereby waives 
any right of subrogation Guarantor has or may have as against Borrower with 
respect to the Guaranteed Obligations. In addition, Guarantor hereby waives 
any right to proceed against Borrower, now or hereafter, for contribution, 
indemnity, reimbursement, and any other suretyship rights and claims, whether 
direct or indirect, liquidated or contingent, whether arising under express 
or implied contract or by operation of law, which Guarantor may now have or 
hereafter have as against the Borrower with respect to the Guaranteed 
Obligations. Guarantor also hereby waives any rights to recourse to or with 
respect to any asset of Borrower Guarantor agrees that in light of the 
immediately forgoing waivers, the execution of this Guaranty shall not be 
deemed to make Guarantor a "creditor" of Borrower, and that for purposes of 
Sections 547 and 550 of the Bankruptcy Code Guarantor shall not be deemed a 
"creditor" of Borrower.

         (e)  WITHOUT LIMITING THE GENERALITY OF ANY OTHER WAIVER OR OTHER 
PROVISION SET FORTH IN THIS GUARANTY, GUARANTOR HEREBY WAIVES, TO THE MAXIMUM 
EXTENT PERMITTED BY LAW, ANY AND ALL BENEFITS OR DEFENSES ARISING DIRECTLY OR 
INDIRECTLY UNDER ANY ONE OR MORE OF CALIFORNIA CIVIL CODE SECTION 2799, 2808, 
2809, 2810, 2815, 2819, 2820, 2821, 2822, 2838, 2839, 2845, 2848, 2849, AND 
2850, CALIFORNIA CODE OF CIVIL PROCEDURE SECTIONS 580a, 580b, 580c, 580d, AND 
726, AND CHAPTER 2 OF TITLE 14 OF THE CALIFORNIA CIVIL CODE.

     7.  RELEASES. Guarantor consents and agrees that, without notice to or 
by Guarantor and without affecting or impairing the obligations of Guarantor 
hereunder, PBC may, by action or inaction:

         (a)  compromise, settle, or extend the duration or the time for the 
payment of, or discharge the performance of, or may refuse to or otherwise 
not enforce the Loan Documents;

         (b)  release all or any one or more parties to any one or more of the
Loan Documents or grant other indulgences to Borrower in respect thereof;

                                     4

<PAGE>

                                                           EXHIBIT 10.4
                                                           PAGE 5 of 8



         (c)  amend or modify in any manner and at any time (or from time to 
time) any of the Loan Documents; or

         (d)  release or substitute any other guarantor, if any, of the 
Guaranteed Obligations, or enforce, exchange, release, or waive any security 
for the Guaranteed Obligations (including, the collateral referred to in 
Section 18 hereof) or any other guaranty of the Guaranteed Obligations, or 
any portion thereof.

     8.  NO ELECTION. PBC shall have the right to seek recourse against 
Guarantor to the fullest extent provided for herein, and no election by PBC 
to proceed in one form of action or proceeding, or against any party, or on 
any obligation, shall constitute a waiver of PBC's right to proceed in any 
other form of action or proceeding or against other parties unless PBC has 
expressly waived such right in writing. Specifically, but without limiting 
the generality of the forgoing, no action or proceeding by PBC under any 
document or instrument evidencing the Guaranteed Obligations shall serve to 
diminish the liability of Guarantor under this Guaranty except to the extent 
that PBC finally and unconditionally shall have realized indefeasible payment 
by such action or proceeding.

     (9)  INDEFEASIBLE PAYMENT.  The Guaranteed Obligations shall not be 
considered indefeasibly paid for purposes of this Guaranty unless and until 
all payments to PBC are no longer subject to any right on the part of any 
person, including Borrower, Borrower as a debtor in possession, or any 
trustee (whether appointed under the Bankruptcy Code or otherwise) of 
Borrower's assets to invalidate or set aside such payments or to seek to 
recoup the amount of such payments or any portion thereof, or to declare same 
to be fraudulent or preferential. Upon such full and final performance and 
indefeasible payment of the Guaranteed Obligations whether by Guarantor or 
Borrower, PBC shall have no obligation whatsoever to transfer or assign its 
interest in the Loan Documents to Guarantor. In the event that, for any 
reason, any portion of such payments to PBC is set aside or restored, whether 
voluntarily or involuntarily, after the making thereof, then the obligation 
intended to be satisfied thereby shall be revived and continued in full force 
and effect as if said payment or payments had not been made, and Guarantor 
shall be liable for the full amount PBC is required to repay plus any and all 
costs and expenses (including attorneys' fees) paid by PBC in connection 
therewith.

     10. FINANCIAL CONDITION OF BORROWER.  Guarantor represents and warrants 
to PBC that Guarantor is currently informed of the financial condition of 
Borrower and of all other circumstances which a diligent inquiry would reveal 
and which bear upon the risk of nonpayment of the Guaranteed Obligations. 
Guarantor further represents and warrants to PBC that Guarantor has read and 
understands the terms and conditions of the Loan Documents. Guarantor hereby 
covenants that Guarantor will continue to keep informed of Borrower's 
financial condition, the financial condition of other guarantors, if any, 
and of all other circumstances which bear upon the risk of nonpayment or 
nonperformance of the Guaranteed Obligations.

     11.  SUBORDINATION.  Guarantor hereby agrees that any and all present 
and future indebtedness of Borrower owing to Guarantor is postponed in favor 
of and subordinated to payment, in full, in cash, of the Guaranteed 
Obligations. In this regard, no payment of any kind whatsoever shall be made 
with respect to such indebtedness until the Guaranteed Obligations have been 
indefeasibly paid in full.

                                     5

<PAGE>

                                                           EXHIBIT 10.4
                                                           PAGE 6 of 8



     12.  PAYMENTS; APPLICATION.  All payments to be made hereunder by 
Guarantor shall be made in lawful money of the United States of America at 
the time of payment, shall be made in immediately available funds, and shall 
be made without deduction (whether for taxes or otherwise) or offset. All 
payments made by Guarantor hereunder shall be applied as follows: first, to 
all costs and expenses (including attorneys' fees) incurred by PBC in 
enforcing this Guaranty or in collecting the Guaranteed Obligations; second, 
to all accrued and unpaid interest, premium, if any, and fees owing to PBC 
constituting Guaranteed Obligations; and third, to the balance of the 
Guaranteed Obligations.

     13.  ATTORNEYS' FEES AND COSTS.  Guarantor agrees to pay, on demand, all 
reasonable attorneys' fees and all other costs and expenses which may be 
incurred by PBC in the enforcement of this Guaranty or in any way arising out 
of, or consequential to the protection, assertion, or enforcement of the 
Guaranteed Obligations (or any security therefor), whether or not suit is 
brought.

     14.  INDEMNIFICATION.  Guarantor agrees to indemnify PBC and hold PBC 
harmless against all obligations, demands, or liabilities asserted by any 
party and against all losses in any way suffered, incurred, or paid by PBC as 
a result of or in any way arising out of, following, or consequential to 
PBC's transactions with Borrower.

     15.  NOTICES.  All notices or demands by Guarantor or PBC to the other 
relating to this Guaranty shall be in writing and either personally served or 
sent by registered or certified mail, postage prepaid, return receipt 
requested, or by prepaid telex, telefacsimile, or telegram, and shall be 
deemed to be given for purposes of this Guaranty on the day that such writing 
is received by the party to whom it is sent. Unless otherwise specified in a 
notice sent or delivered in accordance with the provisions of this section, 
such writing shall be sent, if to Guarantor, then to the attention of Ronald 
G. Lee at Guarantor's address set forth on the signature page hereof, and if 
to PBC, then as follows:

                          PREFERRED BUSINESS CREDIT, INC.
                          300 N. Lake Avenue, Suite 1115
                          Pasadena, California 91101
                          Attn.: President

     16.  CUMULATIVE REMEDIES.  No remedy under this Guaranty or under any 
Loan Document is intended to be exclusive of any other remedy, but each and 
every remedy shall be cumulative and in addition to any and every other 
remedy given hereunder or under any Loan Document, and those provided by law 
or in equity. No delay or omission by PBC to exercise any right under this 
Guaranty shall impair any such right nor be construed to be a waiver thereof. 
No failure on the part of PBC to exercise, and no delay in exercising, any 
right hereunder shall operate as a waiver thereof; nor shall any single or 
partial exercise of any right hereunder preclude any other or further 
exercise thereof or the exercise of any other right.

     17.  BOOKS AND RECORDS.  Guarantor agrees that PBC's books and records 
showing the account between PBC and Borrower shall be admissible in any 
action or proceeding and shall be binding upon Guarantor for the purpose of 
establishing the items therein set forth and shall constitute prima facie 
proof thereof.

                                     6

<PAGE>


                                                                    EXHIBIT 10.4
                                                                    PAGE 7 of 8 

     18. COLLATERAL.  The obligations of Guarantor hereunder are secured, as
provided in that certain n/a.

     19. SEVERABILITY OF PROVISION.  Any provision of this Guaranty which is
prohibited or unenforceable under applicable law, shall be ineffective to the
extent of such prohibition or unenforceability without invalidating the
remaining provisions hereof.

     20. ENTIRE AGREEMENT; AMENDMENTS.  This Guaranty constitutes the entire 
agreement between Guarantor and PBC pertaining to the subject matter 
contained herein.  This Guaranty may not be altered, amended, or modified, 
nor may any provision hereof be waived or noncompliance therewith consented 
to, except by means of a writing executed by both Guarantor and PBC.  Any 
such alteration, amendment, modification, waiver, or consent shall be 
effective only to the extent specified therein and for the specific purpose 
for which given.  No course of dealing and no delay or waiver of any right or 
default under this Guaranty shall be deemed a waiver of any other, similar or 
dissimilar right or default or otherwise prejudice the rights and remedies 
hereunder.

     21. SUCCESSORS AND ASSIGNS.  The death of Guarantor shall not terminate
this Guaranty.  This Guaranty shall be binding upon Guarantor's heirs,
executors, administrators, representatives, successors, and assigns and shall
inure to the benefit of the successors and assigns of PBC; Provided, however,
Guarantor shall not assign this Guaranty or delegate any of its duties hereunder
without PBC's prior written consent.  Any assignment without the consent of PBC
shall be absolutely void.  In the event of any assignment or other transfer of
rights by PBC, the rights and benefits herein conferred upon PBC shall
automatically extend to and be vested in such assignee or other transferee.

     22. SEPARATE PROPERTY.  Any married individual who signs this Guaranty in
his or her individual capacity hereby expressly agrees that recourse may be had
against his or her separate property for all Guaranteed Obligations hereunder.

     23. CHOICE OF LAW AND VENUE.  THE VALIDITY OF THIS GUARANTY, ITS 
CONSTRUCTION, INTERPRETATION, AND ENFORCEMENT, AND THE RIGHTS OF GUARANTOR 
AND PBC, SHALL BE DETERMINED UNDER, GOVERNED BY, AND CONSTRUED IN ACCORDANCE 
WITH THE INTERNAL LAWS OF THE STATE OF CALIFORNIA, WITHOUT REGARD TO 
PRINCIPLES OF CONFLICTS OF LAW.  TO THE MAXIMUM EXTENT PERMITTED BY LAW, 
GUARANTOR HEREBY AGREES THAT ALL ACTIONS OR PROCEEDINGS ARISING IN CONNECTION 
WITH THIS GUARANTY SHALL BE TRIED AND DETERMINED ONLY IN THE STATE AND 
FEDERAL COURTS LOCATED IN THE COUNTY OF LOS ANGELES, STATE OF CALIFORNIA, OR, 
AT THE SOLE OPTION OF PBC, IN ANY OTHER COURT IN WHICH PBC SHALL INITIATE 
LEGAL OR EQUITABLE PROCEEDINGS AND WHICH HAS SUBJECT MATTER JURISDICTION OVER 
MATTER IN CONTROVERSY.  TO THE MAXIMUM EXTENT PERMITTED BY LAW, GUARANTOR 
HEREBY EXPRESSLY WAIVES ANY RIGHT IT MAY HAVE TO ASSERT THE DOCTRINE OF FORUM 
NON CONVENIENS OR TO OBJECT TO VENUE TO THE EXTENT ANY PROCEEDING IS BROUGHT 
IN ACCORDANCE WITH THIS SECTION.

     24. WAIVER OF JURY TRIAL.  TO THE MAXIMUM EXTENT PERMITTED BY LAW,
GUARANTOR HEREBY EXPRESSLY WAIVES ANY RIGHT TO TRIAL BY JURY OF ANY


                                          7

<PAGE>

                                                                    EXHIBIT 10.4
                                                                    PAGE 8 of 8 


ACTION, CAUSE OF ACTION, CLAIM, DEMAND, OR PROCEEDING ARISING UNDER OR WITH
RESPECT TO THIS GUARANTY, OR IN ANY WAY CONNECTED WITH, RELATED TO, OR
INCIDENTAL TO THE DEALINGS OF GUARANTOR AND PBC WITH RESPECT TO THIS GUARANTY,
OR THE TRANSACTIONS RELATED HERETO, IN EACH CASE WHETHER NOW EXISTING OR
HEREAFTER ARISING, AND WHETHER SOUNDING IN CONTRACT, TORT, OR OTHERWISE.  TO THE
MAXIMUM EXTENT PERMITTED BY LAW, GUARANTOR HEREBY AGREES THAT ANY SUCH ACTION,
CAUSE OF ACTION, CLAIM, DEMAND, OR PROCEEDING SHALL BE DECIDED BY A COURT TRIAL
WITHOUT A JURY AND THAT PBC MAY FILE AN ORIGINAL COUNTERPART OF THIS SECTION
WITH ANY COURT OR OTHER TRIBUNAL AS WRITTEN EVIDENCE OF THE CONSENT OF GUARANTOR
TO THE WAIVER OF ITS RIGHT TO TRIAL BY JURY.

     IN WITNESS WHEREOF,  Guarantor has executed and delivered this Guaranty as
of the date set forth in the first paragraph hereof.



                                        /s/ Ronald G. Lee
                                        ---------------------------------------
                                        Ronald G. Lee

               Guarantor's Address:     1147 San Marino Avenue
                                        San Marino, CA 91108

                         Telephone:     (818) 792-1428


                                          8


<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          SEP-30-1998
<PERIOD-START>                             OCT-01-1997
<PERIOD-END>                               JUN-30-1998
<CASH>                                               9
<SECURITIES>                                         0
<RECEIVABLES>                                      909
<ALLOWANCES>                                     (171)
<INVENTORY>                                      2,128
<CURRENT-ASSETS>                                 3,770
<PP&E>                                           6,643
<DEPRECIATION>                                 (6,158)
<TOTAL-ASSETS>                                   6,442
<CURRENT-LIABILITIES>                            4,116
<BONDS>                                              0
                                0
                                          0
<COMMON>                                           413
<OTHER-SE>                                     (2,383)
<TOTAL-LIABILITY-AND-EQUITY>                     6,442
<SALES>                                          6,402
<TOTAL-REVENUES>                                 7,017
<CGS>                                            2,848
<TOTAL-COSTS>                                    7,315
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 470
<INCOME-PRETAX>                                  (859)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                              (859)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (859)
<EPS-PRIMARY>                                    (.20)
<EPS-DILUTED>                                    (.20)
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission